ArticleClinical ophthalmology (Auckland, N.Z.)2025
TRAP1 Improves Diabetic Retinopathy by Preserving Mitochondrial Function.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- SIRT5-mediated HSDL2 desuccinylation promotes diabetic-associated cognitive dysfunction via disrupting mitochondrial TRAP1.Cell biology and toxicology · 2026Article
- Ferroptosis in diabetic retinopathy: cellular heterogeneity, progression, and therapeutic targets.Molecular biology reports · 2026Review
- Ferroptosis and the eye: bridging the gap between cell death and vision preservation.Frontiers in immunology · 2026Review
- TRAP1 Improves Diabetic Retinopathy by Preserving Mitochondrial Function.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recent studies have demonstrated that mitochondrial dysfunction is pivotal in early diabetic retinopathy (DR). Tumor necrosis factor-associated protein 1 (TRAP1), a mitochondrial chaperone regulating stress responses, remains unexplored in DR pathogenesis. Methods: We established in vivo and in vitro models of DR. Hematoxylin and eosin (H&E) staining was utilized to evaluate retinal lesions in rats. Western blotting, reverse transcription quantitative polymerase chain reaction (RT-qPCR), and immunofluorescence staining were employed to assess TRAP1 expression in the retina. Cell viability, reactive oxygen species (ROS), mitochondrial damage, and TRAP1 expression levels were measured in ARPE-19 cells. RNA sequencing (RNA-seq) identified gene expression and pathway changes in shTRAP1 cells. The role of TRAP1 in ferroptosis in ARPE-19 cells was evaluated with or without ferrostatin-1 (Fer-1) and erastin. Potential ferroptosis-related proteins interacting with TRAP1 were validated using co-immunoprecipitation (CO-IP) techniques. This study confirmed TRAP1's critical role in the pathogenesis of DR. Results: Our findings elucidate a significant reduction in TRAP1 expression in diabetic rat retinas, particularly in the pigment epithelium. High glucose levels correspondingly diminished TRAP1 expression in ARPE-19 cells, causing decreased cellular viability, increased ROS generation, and mitochondrial dysfunction. Notably, the overexpression of TRAP1 effectively preserved mitochondrial homeostasis under stress, mitigated mitochondrial impairment, and enhanced cellular viability. Importantly, TRAP1 may alleviate hyperglycemia-induced mitochondrial damage by reducing ferroptosis through its interactions with ferroptosis-related proteins, including acyl-CoA synthetase long-chain family member 1 (ACSL1), acyl-CoA synthetase long-chain family member 4 (ACSL4), and cytochrome b5 reductase 1 (CYB5R1). Conclusion: TRAP1 exerts a protective influence on mitochondrial function in ARPE-19 cells. Reduced levels of TRAP1 may play a crucial role as an early contributor to mitochondrial dysfunction in diabetic retinopathy. Furthermore, the association of TRAP1 with ferroptosis improves cellular viability by enhancing mitochondrial resilience against high glucose-induced stressors and preventing cellular ferroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.